Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals shares declined 9.75 percent on over five times the average daily volume Monday to close at $5.00 a share. The company swung to a net loss of $13.5 million for the fourth quarter of 2012, compared to a net income of $81.1 million in the year ago quarter.
Going forward ... (see research report)
Subscribe to News Feeds